IMPROVED SURVIVAL AFTER A MEDIAN FOLLOW-UP OF 6 YEARS FOR IMMUNOCHEMOTHERAPY (R-MCP) VERSUS CHEMOTHERAPY ALONE (MCP) IN ADVANCED FOLLICULAR LYMPHOMA (FL) - UPDATE OF THE OSHO#39 TRIAL
ANNALS OF ONCOLOGY(2011)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要